Immix Biopharma cuts target price to $22 from $23
IMMX•Mizuho cut its target price for Immix Biopharma to $22 from $23.
Related News

Nasdaq trade halt continues; reason not available at 7:25 a.m.
SSTI•

Canadian Solar unit wins X-ELIO orders for five battery storage projects
CSIQ•

Target heads into holiday season with brighter sales outlook
TGT•

Aquestive Therapeutics presents at Piper Sandler 38th Annual Healthcare Conference
AQST•

Carlyle agrees to sell AGILOX to Rockwell Automation
ROK•